Related Experiment Video
Updated: Jul 30, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Acrolein produced during acute kidney injury promotes tubular cell death
Seishi Aihara1, Kumiko Torisu2, Yutaro Hirashima1
1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract:
Acute kidney injury is an important global health concern as it is associated with high morbidity and mortality. Polyamines, essential for cell growth and proliferation, are known to inhibit cardiovascular disease. However, under conditions of cellular damage, toxic acrolein is produced from polyamines by the enzyme spermine oxidase (SMOX). We used a mouse renal ischemia-reperfusion model and human proximal tubule cells (HK-2) to investigate whether acrolein exacerbates acute kidney injury by renal tubular cell death. Acrolein visualized by acroleinRED was increased in ischemia-reperfusion kidneys, particularly in tubular cells. When HK-2 cells were cultured under 1% oxygen for 24 h, then switched to 21% oxygen for 24 h (hypoxia-reoxygenation), acrolein accumulated and SMOX mRNA and protein levels were increased. Acrolein induced cell death and fibrosis-related TGFB1 mRNA in HK-2 cells. Administration of the acrolein scavenger cysteamine suppressed the acrolein-induced upregulation of TGFB1 mRNA. Cysteamine also inhibited a decrease in the mitochondrial membrane potential observed by MitoTrackerCMXRos, and cell death induced by hypoxia-reoxygenation. The siRNA-mediated knockdown of SMOX also suppressed hypoxia-reoxygenation-induced acrolein accumulation and cell death. Our study suggests that acrolein exacerbates acute kidney injury by promoting tubular cell death during ischemia-reperfusion injury. Treatment to control the accumulation of acrolein might be an effective therapeutic option for renal ischemia-reperfusion injury.
Insights
Toxic acrolein, produced from polyamines during cell damage, worsens acute kidney injury (AKI) by causing tubular cell death. Controlling acrolein levels may offer a new therapeutic strategy for kidney ischemia-reperfusion injury.
Area of Science:
- Nephrology
- Cellular Biology
- Toxicology
Background:
- Acute kidney injury (AKI) presents a significant global health challenge with high morbidity and mortality rates.
- Polyamines are crucial for cellular functions, but their breakdown product, acrolein, can be toxic.
- Spermine oxidase (SMOX) is an enzyme responsible for producing acrolein from polyamines during cellular damage.
Purpose of the Study:
- To investigate the role of acrolein in exacerbating AKI through renal tubular cell death.
- To explore the therapeutic potential of targeting acrolein accumulation in ischemia-reperfusion injury.
Main Methods:
- Utilized a mouse model of renal ischemia-reperfusion injury and human proximal tubule cells (HK-2).
- Quantified acrolein levels using acroleinRED and assessed SMOX expression.
- Investigated the effects of acrolein and its scavenger cysteamine on cell death and fibrosis markers (TGFB1).
- Examined mitochondrial membrane potential and employed siRNA-mediated knockdown of SMOX.
Main Results:
- Acrolein levels were elevated in ischemia-reperfusion injured kidneys and in HK-2 cells undergoing hypoxia-reoxygenation.
- Acrolein exposure induced cell death and increased TGFB1 mRNA expression in HK-2 cells.
- Cysteamine treatment reduced acrolein-induced TGFB1 upregulation, preserved mitochondrial membrane potential, and decreased cell death.
- SMOX knockdown mitigated hypoxia-reoxygenation-induced acrolein accumulation and cell death.
Conclusions:
- Acrolein significantly contributes to renal tubular cell death and exacerbates AKI during ischemia-reperfusion injury.
- Targeting acrolein accumulation, potentially via scavengers like cysteamine, represents a promising therapeutic avenue for AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management

